We showed that ATP6AP2 knockdown or CD47 blockade alone inhibited tumorigenicity of SW620 and DLD1 in mice, and a combination of ATP6AP2 knockdown and CD47 blockade elicited a strong inhibition of tumor growth and development (Figures 4A, B). This evidence concerns the gene CD47 and neoplasm.